Notably, triple combination of siRNA for cyclin D1 and Mcl-1, with P276-00 is significantly effective as compared to drug alone suggestive of the need for inhibition of multiple pathways for proficient therapy for MCL. Here, MCL1 is linked to mantle cell lymphoma.